Richard Scott Struthers - Mar 16, 2023 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
President & CEO, Director
Signature
/s/ Marc Wilson, as attorney-in-fact
Stock symbol
CRNX
Transactions as of
Mar 16, 2023
Transactions value $
-$79,231
Form type
4
Date filed
3/17/2023, 05:10 PM
Previous filing
Mar 3, 2023
Next filing
Jun 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Tax liability -$79.2K -4.63K -3.56% $17.12 126K Mar 16, 2023 Direct F1
holding CRNX Common Stock 1K Mar 16, 2023 By Spouse
holding CRNX Common Stock 731K Mar 16, 2023 By Family Trust 1
holding CRNX Common Stock 90K Mar 16, 2023 By Family Trust 2
holding CRNX Common Stock 90K Mar 16, 2023 By Family Trust 3
holding CRNX Common Stock 90K Mar 16, 2023 By Family Trust 4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on February 28, 2022. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.